AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2017

Apr 4, 2017

31971_dirs_2017-04-04_b3c23431-1641-4b88-894c-9cf1a96647e3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2017-04-03

Reporting Person: Farkas Charles (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-03	Common Stock	P	180	$44.41	Acquired	8505	Direct

Footnotes

F1: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 27, 2017.